Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9813-9821
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9813
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9813
Table 6 Stratified analyses of rs303218 and virological response
Variables | No./total1 | rs303218 | ||
OR | 95%CI | P value2 | ||
Age (yr) | ||||
≤ 26 | 39/117 | 0.79 | 0.42-1.48 | 0.453 |
> 26 | 44/108 | 0.59 | 0.33-1.04 | 0.070 |
Gender | ||||
Male | 55/163 | 0.53 | 0.32-0.88 | 0.0133 |
Female | 28/62 | 1.03 | 0.46-2.31 | 0.947 |
Baseline ALT | ||||
≤ 150 | 38/113 | 0.38 | 0.20-0.74 | 0.0033 |
> 150 | 45/112 | 0.91 | 0.52-1.60 | 0.734 |
Baseline AST | ||||
≤ 83 | 34/114 | 0.31 | 0.16-0.61 | 0.0013 |
> 83 | 49/111 | 1.10 | 0.62-1.96 | 0.752 |
Baseline HBV DNA copies (log10 IU/mL) | ||||
≤ 7.36 | 47/113 | 0.86 | 0.49-1.52 | 0.611 |
> 7.36 | 36/112 | 0.47 | 0.25-0.88 | 0.0183 |
HBV genotype | ||||
Type B | 42/94 | 0.74 | 0.42-1.31 | 0.304 |
Type C | 10/15 | 2.19 | 0.36-13.51 | 0.397 |
Type B + C | 22/80 | 0.41 | 0.19-0.86 | 0.0183 |
- Citation: Xie DY, Wang SM, Yang JM, Wang LH, Chen HY, Huai C, Shang J, Mao Q, Lei CL, Luo GH, Qian J, Lu DR. IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection. World J Gastroenterol 2016; 22(44): 9813-9821
- URL: https://www.wjgnet.com/1007-9327/full/v22/i44/9813.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i44.9813